The Role of Filamin in Periventricular Heterotopias
细丝蛋白在脑室周围异位中的作用
基本信息
- 批准号:6896101
- 负责人:
- 金额:$ 17.15万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-07-16 至 2007-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Developmental disorders of the human
cerebral cortex comprise 15-40 percent of epilepsy cases, most notably
intractable pediatric seizures. These disorders have deleterious affects on
both the psychological and physical well being of individuals. Identification
of the causative genes and characterization of their function will provide
necessary insight into the neuropathology of epilepsy as well as extend the
current understanding of normal cortical development. Through such a genetic
approach, recent findings have shown that mutations in the actin-binding
protein filamin I (FLN1) are implicated in the human x-linked disorder,
periventricular heterotopia and epilepsy (PVH). This neurogenetic disorder is
characterized by the failure of subsets of neurons to migrate from the
ventricle during corticogenesis, in association with thinning of the corpus
callosum and cerebellar hypoplasia. While the filamin proteins are known to
regulate cell stability, protrusion and motility across various biologic
systems, their potential functions within the central nervous system has only
just come to light with the recent association of FLNI to PVH. Thus, the
overall goal of this proposal is to analyze the roles of FLN1 and a highly
homologous protein, FLN3, in relation to neurogenesis, neuronal migration, and
subsequent differentiation.
Specific Aim 1 will characterize the temporal and spatial pattern of filamin
protein and mRNA expression, to test the hypothesis that the actin-binding
proteins localize to appropriate neuronal populations during periods of ongoing
cortical neurogenesis, migration and axonal outgrowth. Specific Aim 2 will
identify protein-protein interactions between FLN1, FLN3 and other novel and
known developmental genes, to test the hypothesis that filamin proteins are
involved in signal transduction pathways essential to cortical development.
Specific Aim 3 will directly evaluate the functional significance of such
interactions through generation of dominant-negative and overexpression
constructs. FLN1 mutant mice will also provide an animal model with which to
study filamin interactions during the various stages of neuronal development.
The candidate has completed training in both medical and graduate programs. His
residency training is in Neurology, and he earned his doctoral degree in
Neuroscience studying neocortical transplantation paradigms in effecting
neuronal specification, migration and directed differentiation during both
cortical development and following targeted neuronal degeneration. He now seeks
further training under the mentorship of Dr. Chris Walsh, whose research
interests center on genetic approaches toward understanding fundamental
mechanisms governing development of the cerebral cortex. It is the candidate's
intention to combine these newly acquired molecular and genetic approaches with
his prior training in transplantation to pursue an academic career in Neurology
and the Neurosciences, primarily in the field of cortical development and
malformations as they pertain to epilepsy.
描述(由申请人提供):人类发育障碍
大脑皮层占癫痫病例的 15-40%,最值得注意的是
顽固性小儿癫痫发作。这些疾病会对身体产生有害影响
个人的心理和身体健康。鉴别
致病基因及其功能的表征将提供
对癫痫的神经病理学有必要的了解,并扩展
目前对正常皮质发育的理解。通过这样的遗传
方法,最近的研究结果表明,肌动蛋白结合的突变
蛋白丝蛋白 I (FLN1) 与人类 x 连锁疾病有关,
脑室周围异位和癫痫(PVH)。这种神经遗传性疾病是
其特征是神经元子集无法从
皮质发生过程中的心室,与语体变薄相关
胼胝体和小脑发育不全。虽然已知细丝蛋白
调节各种生物制剂中的细胞稳定性、突出和运动性
系统,它们在中枢神经系统内的潜在功能仅
最近 FLNI 与 PVH 的关联才刚刚曝光。因此,
该提案的总体目标是分析 FLN1 的作用和高度
同源蛋白 FLN3 与神经发生、神经元迁移和
后续分化。
具体目标 1 将表征细丝蛋白的时间和空间模式
蛋白质和 mRNA 表达,以检验肌动蛋白结合的假设
在持续的过程中,蛋白质定位到适当的神经元群体
皮质神经发生、迁移和轴突生长。具体目标 2 将
鉴定 FLN1、FLN3 和其他新的和
已知的发育基因,以检验细丝蛋白是
参与皮质发育必需的信号转导途径。
具体目标3将直接评估此类的功能意义
通过显性失活和过度表达的产生相互作用
构造。 FLN1突变小鼠还将提供一种动物模型
研究神经元发育各个阶段的细丝蛋白相互作用。
候选人已完成医学和研究生课程的培训。他的
他接受了神经病学住院医师培训,并获得了博士学位
神经科学研究新皮质移植范式的影响
神经元的规范、迁移和定向分化
皮质发育和随后的目标神经元变性。他现在寻求
在 Chris Walsh 博士的指导下进一步接受培训,他的研究
兴趣集中在理解基本原理的遗传方法上
控制大脑皮层发育的机制。这是候选人的
打算将这些新获得的分子和遗传学方法与
他之前接受过移植培训,以从事神经病学的学术生涯
和神经科学,主要是在皮质发育和
与癫痫有关的畸形。
项目成果
期刊论文数量(16)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Mutation in filamin A causes periventricular heterotopia, developmental regression, and West syndrome in males.
细丝蛋白 A 的突变会导致男性脑室周围异位、发育退化和 West 综合征。
- DOI:
- 发表时间:2006-01
- 期刊:
- 影响因子:5.6
- 作者:Masruha, Marcelo R;Caboclo, Luis O S F;Carrete Jr, Henrique;Cendes, Iscia L;Rodrigues, Murilo G;Garzon, Eliana;Yacubian, Elza M T;Sakamoto, Americo C;Sheen, Volney;Harney, Megan;Neal, Jason;Hill, R Sean;Bodell, Adria;Walsh, Christopher;Vilan
- 通讯作者:Vilan
Cerebral developmental disorders.
大脑发育障碍。
- DOI:
- 发表时间:2006-12
- 期刊:
- 影响因子:3.6
- 作者:Lian, Gewei;Sheen, Volney
- 通讯作者:Sheen, Volney
Cerebellar ataxia with progressive improvement.
小脑共济失调逐渐改善。
- DOI:
- 发表时间:2006-04
- 期刊:
- 影响因子:0
- 作者:Tsao, Jack W;Neal, Jason;Apse, Kira;Stephan, Mark J;Dobyns, William B;Hill, Robert S;Walsh, Christopher A;Sheen, Volney L
- 通讯作者:Sheen, Volney L
Malformations of cortical development.
皮质发育畸形。
- DOI:
- 发表时间:2008-05
- 期刊:
- 影响因子:0
- 作者:Pang, Trudy;Atefy, Ramin;Sheen, Volney
- 通讯作者:Sheen, Volney
Images in clinical medicine. Herpes zoster ophthalmicus followed by contralateral hemiparesis.
临床医学中的图像。
- DOI:
- 发表时间:2002-04-11
- 期刊:
- 影响因子:0
- 作者:Nogueira, Raul G;Sheen, Volney L
- 通讯作者:Sheen, Volney L
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
VOLNEY L SHEEN其他文献
VOLNEY L SHEEN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('VOLNEY L SHEEN', 18)}}的其他基金
Down Syndrome: a potential treatment XISTs
唐氏综合症:一种潜在的治疗方法 XIST
- 批准号:
10525816 - 财政年份:2022
- 资助金额:
$ 17.15万 - 项目类别:
Deciphering HSA21 genes associated with Alzheimers disease in Down Syndrome
破译与唐氏综合症中阿尔茨海默病相关的 HSA21 基因
- 批准号:
10120793 - 财政年份:2019
- 资助金额:
$ 17.15万 - 项目类别:
Epigenetic Silencing of HSA21 in Down Syndrome
唐氏综合症中 HSA21 的表观遗传沉默
- 批准号:
9892127 - 财政年份:2019
- 资助金额:
$ 17.15万 - 项目类别:
Epigenetic Silencing of HSA21 in Down Syndrome
唐氏综合症中 HSA21 的表观遗传沉默
- 批准号:
10016836 - 财政年份:2019
- 资助金额:
$ 17.15万 - 项目类别:
Cellular and Molecular Mechanisms in Periventricular Heterotopia
脑室周围异位的细胞和分子机制
- 批准号:
8470253 - 财政年份:2009
- 资助金额:
$ 17.15万 - 项目类别:
Cellular and Molecular Mechanisms in Periventricular Heterotopia
脑室周围异位的细胞和分子机制
- 批准号:
8078196 - 财政年份:2009
- 资助金额:
$ 17.15万 - 项目类别:
Cellular and Molecular Mechanisms in Periventricular Heterotopia
脑室周围异位的细胞和分子机制
- 批准号:
8269069 - 财政年份:2009
- 资助金额:
$ 17.15万 - 项目类别:
Cellular and Molecular Mechanisms in Periventricular Heterotopia
脑室周围异位的细胞和分子机制
- 批准号:
7729307 - 财政年份:2009
- 资助金额:
$ 17.15万 - 项目类别:
Human Neural Precursors from CNS Developmental Disorders: Down Syndrome
中枢神经系统发育障碍的人类神经前体:唐氏综合症
- 批准号:
7602965 - 财政年份:2008
- 资助金额:
$ 17.15万 - 项目类别:
Human Neural Precursors from CNS Developmental Disorders: Down Syndrome
中枢神经系统发育障碍的人类神经前体:唐氏综合症
- 批准号:
7470915 - 财政年份:2008
- 资助金额:
$ 17.15万 - 项目类别:
相似国自然基金
METTL14介导NR2F1的m6A修饰调控妊娠期高血糖胚胎额叶皮层神经干细胞的分化和迁移
- 批准号:82301932
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
CXCL14/c-JUN正反馈轴在牙移动中调节牙周膜细胞成骨关键亚群定向迁移和成骨分化的机制研究
- 批准号:82370998
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
脑卒中后自主神经功能紊乱通过抑制肠源性IgA+浆细胞分化和迁移加剧神经炎症的机制研究
- 批准号:82301456
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
骨植入材料表面微结构通过破骨前体细胞迁移体中Pten mRNA调控其分化成熟的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:
白芍总苷及组分调控肠黏膜免疫CD4+Th17细胞分化与迁移治疗干燥综合征的作用及机制研究
- 批准号:
- 批准年份:2021
- 资助金额:55 万元
- 项目类别:面上项目
相似海外基金
A novel role for Wasl signaling in the regulation of skeletal patterning
Wasl 信号在骨骼模式调节中的新作用
- 批准号:
10718448 - 财政年份:2023
- 资助金额:
$ 17.15万 - 项目类别:
Annexin A2 as a cerebrovascular therapy in traumatic brain injury
膜联蛋白 A2 作为创伤性脑损伤的脑血管疗法
- 批准号:
9986277 - 财政年份:2019
- 资助金额:
$ 17.15万 - 项目类别:
Integrin-Matrix Regulation of IPF Fibroblast Phenotype
IPF 成纤维细胞表型的整合素基质调节
- 批准号:
9099865 - 财政年份:2015
- 资助金额:
$ 17.15万 - 项目类别:
Alcohol Regulation of Resident Vascular Stem Cells.
驻留血管干细胞的酒精调节。
- 批准号:
9107329 - 财政年份:2015
- 资助金额:
$ 17.15万 - 项目类别:
Annexin A2 as a cerebrovascular therapy in traumatic brain injury
膜联蛋白 A2 作为创伤性脑损伤的脑血管疗法
- 批准号:
9231513 - 财政年份:2015
- 资助金额:
$ 17.15万 - 项目类别: